Saturday, January 27, 2018 3:56:15 PM
Greetings.
On the basis of the sound physics and biology of this company's technology, and its very significant and apparently facilitated ability to eventually gain FDA approval for clinical use, I've taken a small, initial position (at $0.34).
Presently things are quiet. That is understood. I have only the slightest concern that my small position will not eventually be rewarding.
But regarding that, can anyone lay out plausible share-price outcomes for IMEXF in a year or two, when their multispectral cystoscopes will be probing the bladders (and perhaps other organs) of many?
Will IMEXF mature out at $10, $20, $50, or higher? Anyone studied this, with useful projections or conjectures?
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM